<ѻýҕl>Appendectomy Linked to Higher Risk of Microscopic Colitisѻýҕl> Risk remained elevated over 10 years, Swedish study showed Jun 17, 2022
<ѻýҕl>Biologics for Crohn's Go Head to Headѻýҕl> Ustekinumab, adalimumab both effective in SEAVUE trial, with no difference in remissions Jun 13, 2022
<ѻýҕl>Risankizumab Eases Moderate to Severe Crohn's Diseaseѻýҕl> Induction and maintenance trials showed higher clinical remission with subcutaneous and IV doses Jun 06, 2022
<ѻýҕl>Maintenance Mirikizumab Proves Mettle in Ulcerative Colitisѻýҕl> In LUCENT-2, clinical remissions doubled among responders to induction therapy May 26, 2022
<ѻýҕl>Etrasimod Shows Promise in Moderate to Severe Ulcerative Colitisѻýҕl> Analysis of two ELEVATE trials showed significant improvements in clinical remission May 25, 2022
<ѻýҕl>Antibiotics Heighten Risk for IBD in Seniorsѻýҕl> Registry-based study finds association with antibiotics that target gastrointestinal pathogens May 13, 2022
<ѻýҕl>Unusual Hepatitis Spreads; IBD and Erectile Dysfunction; Can PFAS Harm Livers?ѻýҕl> News and commentary from the world of gastroenterology and hepatology Apr 28, 2022
<ѻýҕl>Perianal Fistulas in Crohn's Signal Greater Disease Burdenѻýҕl> U.S. registry finds greater medication use and twice as many IBD-related surgeries Apr 27, 2022
<ѻýҕl>Pregnant Woman With Crohn's Disease Experiences Perianal Painѻýҕl> Pain may be sole symptom of Fournier's gangrene in the immunosuppressed Apr 25, 2022
<ѻýҕl>Crohn's Fistulas Heal Better With Combined Surgical-TNF Blocker Approachѻýҕl> Some, but not all, key outcomes prove better in clinical trial Apr 18, 2022
<ѻýҕl>Pre-Op TNF Blockers Cleared of Infection Risk in IBD Patientsѻýҕl> Largest prospective cohort study finds no increase in postoperative infections Apr 14, 2022
<ѻýҕl>Rinvoq Approved for UC; HCC Combo Flops; Disney Grants Pass to IBS Patientѻýҕl> News and commentary from the world of gastroenterology and hepatology Mar 17, 2022
<ѻýҕl>Kids With IBD Need Close Monitoring as They Grow Upѻýҕl> Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
<ѻýҕl>Surveillance Colonoscopy in IBD Tied to Lower Advanced Cancer Riskѻýҕl> Findings bolster guidelines for IBD patients with extensive colitis or left-sided colitis Mar 01, 2022
<ѻýҕl>Ulcerative Colitis With an Unexpected Causeѻýҕl> Can the immune response to COVID-19 trigger inflammatory bowel disease? Mar 01, 2022
<ѻýҕl>SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Dietѻýҕl> News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
<ѻýҕl>Guselkumab Cuts Disease Activity in Crohn'sѻýҕl> Nearly two-thirds of patients respond to selective p19 IL-23 inhibitor Feb 08, 2022
<ѻýҕl>Trial Data Confirm Heightened Risks With JAK Inhibitorѻýҕl> May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
<ѻýҕl>Simpler Tool Validated for Endoscopic Assessment in Crohn'sѻýҕl> SEMA-CD should be used as endpoint for clinical trials, researcher argues Jan 26, 2022
<ѻýҕl>Vedolizumab for Ulcerative Colitis Works Best When Given Earlyѻýҕl> Benefit confirmed in real-world data Jan 25, 2022
<ѻýҕl>Combo Treatment Disappoints in Acute Severe Ulcerative Colitisѻýҕl> No outcomes boost with addition of 5-ASA agent to corticosteroids in hospitalized patients Jan 23, 2022
<ѻýҕl>Patients With IBD Cite Symptom Relief With Online Intervention Toolѻýҕl> But experts warns that patients were on the very strict Specific Carbohydrate Diet Jan 22, 2022
<ѻýҕl>Which IBD Patients Experience More Severe COVID?ѻýҕl> Research suggests immunomodulators, incomplete vaccination, and non-mRNA vaccines may play a role Jan 21, 2022
<ѻýҕl>Crohn's Disease Scores With Interchangeable Humira Biosimilarѻýҕl> "Non-medical switches" will be less of a concern when new treatment option becomes available Dec 31, 2021
<ѻýҕl>Non-Invasive Nerve Stimulation Shows Promise for Younger IBD Patientsѻýҕl> Small pilot study found many children and young adults achieved clinical remission Dec 15, 2021
<ѻýҕl>Year in Review: Crohn's Diseaseѻýҕl> First interchangeable biosimilar approved, biologics go head-to-head Dec 15, 2021
<ѻýҕl>For IBD Patients, Too Much Processed Meat May Be Deadlyѻýҕl> Study investigates diet's link to all-cause mortality, not just IBD incidence Dec 14, 2021
<ѻýҕl>No Extra C. Diff Risk Observed With Vedolizumab in Ulcerative Colitisѻýҕl> Retrospective study found no increased risk versus anti-TNF agents, but more research is needed Dec 11, 2021
<ѻýҕl>Time Doesn't Heal Parents' Mental Health Wounds From Kids' IBD Dxѻýҕl> "I was surprised" by these results, researcher says Dec 10, 2021
<ѻýҕl>Biologics vs Small Molecule Drugs for UC: Which Agent Emerged on Top?ѻýҕl> The most effective drug not necessarily the safest Dec 01, 2021
<ѻýҕl>JAK Inhibitor Maintenance Works in Severe Ulcerative Colitisѻýҕl> Treatment group achieved clinical remission, met clinical secondary endpoints Oct 29, 2021
<ѻýҕl>Maintenance IL-23 Blockade Yields Durable Benefit in Crohn's Diseaseѻýҕl> Over 50% of patients responding to induction risankizumab maintained clinical remission at 1 year Oct 28, 2021
<ѻýҕl>How Should Patients With Autoimmune Diseases Approach COVID Vaccination?ѻýҕl> Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<ѻýҕl>First Interchangeable Humira Biosimilar Approvedѻýҕl> Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<ѻýҕl>IBD and Pediatric Arthritis: Exploring the Linkѻýҕl> Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
<ѻýҕl>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risksѻýҕl> Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<ѻýҕl>Proton Pump Inhibitors and IBD: What's the Link?ѻýҕl> Use tied to "modest" increase in risk for ulcerative colitis, Crohn's in observational studies Aug 12, 2021
<ѻýҕl>COVID-19 Antibody Response in IBD Patients Quickly Wanesѻýҕl> Canadian study emphasizes importance of vaccination in this population, researcher says Aug 04, 2021
<ѻýҕl>Two Ulcerative Colitis Biologics: Same Clinical Difference?ѻýҕl> One may have additional clinical benefits, post-hoc analysis suggested Aug 02, 2021
<ѻýҕl>New-Onset IBD and IL-17 Inhibitors: What Is the Risk?ѻýҕl> Underlying inflammatory disease severity should be taken into account Jul 21, 2021